Early coagulopathy predicts mortality in trauma.

BACKGROUND Coagulopathy and hemorrhage are known contributors to trauma mortality; however, the actual relationship of prothrombin time (PT) and partial thromboplastin time (PTT) to mortality is unknown. Our objective was to measure the predictive value of the initial coagulopathy profile for trauma-related mortality. METHODS We reviewed prospectively collected data on trauma patients presenting to a Level I trauma center. A logistic regression analysis was performed of PT, PTT, platelet count, and confounders to determine whether coagulopathy is a predictor of all-cause mortality. RESULTS From a trauma registry cohort of 20103 patients, 14397 had complete disposition data for initial analysis and 7638 had complete data for all variables in the final analysis. The total cohort was 76.2% male, the mean age was 38 years (range, 1-108 years), and the median Injury Severity Score was 9. There were 1276 deaths (all-cause mortality, 8.9%). The prevalence of coagulopathy early in the postinjury period was substantial, with 28% of patients having an abnormal PT (2994 of 10790) and 8% of patients having an abnormal PTT (826 of 10453) on arrival at the trauma bay. In patients with disposition data and a normal PT, 489 of 7796 died, as compared with 579 of 2994 with an abnormal PT (6.3% vs. 19.3%; chi2 = 414.1, p < 0.001). Univariate analysis generated an odds ratio of 3.6 (95% confidence interval [CI], 3.15-4.08; p < 0.0001) for death with abnormal PT and 7.81 (95% CI, 6.65-9.17; p < 0.001) for deaths with an abnormal PTT. The PT and PTT remained independent predictors of mortality in a multiple regression model, whereas platelet count did not. The model also included the independent risk factors age, Injury Severity Score, scene and trauma-bay blood pressure, hematocrit, base deficit, and head injury. The model generated an adjusted odds ratio of 1.35 for PT (95% CI, 1.11-1.68; p < 0.001) and 4.26 for PTT (95% CI, 3.23-5.63; p < 0.001). CONCLUSION The incidence of coagulation abnormalities, early after trauma, is high and they are independent predictors of mortality even in the presence of other risk factors. An initial abnormal PT increases the adjusted odds of dying by 35% and an initial abnormal PTT increases the adjusted odds of dying by 326%.

[1]  J. Holcomb,et al.  The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries. , 2002, The Journal of trauma.

[2]  S. Cohn,et al.  Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot study. , 2002, The Journal of trauma.

[3]  A. Scope,et al.  Does prehospital fluid administration impact core body temperature and coagulation functions in combat casualties? , 2002, Injury.

[4]  E. Segal,et al.  Recombinant activated factor VII for adjunctive hemorrhage control in trauma. , 2001, The Journal of trauma.

[5]  P. Pezzotti,et al.  The Influence of Hemocoagulative Disorders on the Outcome of Children with Head Injury , 2001, Pediatric Neurosurgery.

[6]  R. Reiss,et al.  Hemostatic defects in massive transfusion: rapid diagnosis and management. , 2000, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[7]  C. Waydhas,et al.  High-dose antithrombin III treatment of severely injured patients: results of a prospective study. , 1997, The Journal of trauma.

[8]  A. Sauaia,et al.  Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. , 1997, The Journal of trauma.

[9]  Jeffrey S. Young,et al.  Coagulopathy in severe closed head injury: is empiric therapy warranted? , 1997, The American surgeon.

[10]  B. Selladurai,et al.  Coagulopathy in acute head injury--a study of its role as a prognostic indicator. , 1997, British journal of neurosurgery.

[11]  E. Frank,et al.  Blunt brain injury activates the coagulation process. , 1996, Archives of surgery.

[12]  R. L. Fulton,et al.  Predicting the need to pack early for severe intra-abdominal hemorrhage. , 1996, The Journal of trauma.

[13]  Richard W. Davis.  Massive blood transfusion in a tertiary referral hospital , 1996, The Medical journal of Australia.

[14]  R. E. Clark,et al.  A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. , 1995, Circulation.

[15]  A. Sauaia,et al.  Epidemiology of trauma deaths: a reassessment. , 1993, The Journal of trauma.

[16]  S. Gando,et al.  Posttrauma coagulation and fibrinolysis , 1992, Critical care medicine.

[17]  S. Stein,et al.  Delayed brain injury after head trauma: significance of coagulopathy. , 1992, Neurosurgery.

[18]  J. Hiatt,et al.  Coagulopathy and catecholamines in severe head injury. , 1991, The Journal of trauma.

[19]  J. Macarthur,et al.  Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion , 1990 .

[20]  S. Fava,et al.  Coagulation abnormalities in patients with head injury. , 1986, Journal of neurosurgical sciences.

[21]  G. Ordog,et al.  Coagulation abnormalities in traumatic shock. , 1985, Annals of emergency medicine.

[22]  D. Silver,et al.  Fibrinolytic response to trauma. , 1984, Surgery.

[23]  F. Preston,et al.  Disseminated intravascular coagulation as a consequence of cerebral damage , 1974, Journal of neurology, neurosurgery, and psychiatry.

[24]  J. Stremple,et al.  Coagulopathy after Major Combat Injury: Occurrence, Management, and Pathophysiology , 1972, Annals of surgery.

[25]  R. Cowley,et al.  Alterations in coagulation and fibrinolytic mechanisms in acute trauma. , 1969, The Journal of trauma.